# Amylyx Stock Surges 55% After GLP-1 Blocker Hits All Trial Goals

> **Open Intelligence Dossier** · First detected: 2026-08-19 01:07 UTC · Category: Business

## Executive Summary
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Amylyx Stock Surges 55% After GLP-1 Blocker Hits All Trial Goals" is generating significant coverage in the Business category, with 6 articles from 4 distinct sources tracked by PULSE so far.


Outlets currently covering the story include The Boston Globe, BioPharma Dive, Yahoo Finance and Fierce Biotech. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| The Boston Globe | Amylyx endocrine drug succeeds in pivotal study | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxQbFoySUdLS05FYk01VWQ1RjhObjVxWG9Nak1rSk5CdVRjam8wTEV3TlB1bmFUcGJkUFRONS1fSUpSN2Q4eWg4dHE4RFhhcUJjVkhYeHpGQTFHM0xlNXZZYm5YNnU2cHYybGtwdVNlS2k5a3BTRkVRSW1nX3VmUnRhZFlISGFGeTN6MUFUemJfZ2hlT3NpZnVSMA?oc=5) |
| BioPharma Dive | Amylyx’s bet on a GLP-1 blocker pays off | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxQNzNfSndPazdFLWxnZjAtdHoyNmNiaEY0RGFtcDROeHFxczdmZFQ5a0xWODBzRzNPMkd0dS1FZFBQMTdqVVFvU0VnWGdoTU5OV1J6c2dnVE9xdmJZTU1abmNLQlQtNW1SUVRqUm95T1pHbGRBZE45RGt0MkllaGtCMEFwM2dYa3dPSDQtVnFnSjJGOTJLRHExb3RlUWZzS2pZ?oc=5) |
| Yahoo Finance | Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today? | [Source Link](https://news.google.com/rss/articles/CBMijwFBVV95cUxORmNmWG5MLTNwZ0x3Ti1UWUFqb3hNc0hjV2Fybjl3UzczR2dVSFdtb2ViT0xrQmdrV3BVR2hIdVlNa21QUllpSFZXRS1HRmJWU0EyWGE4SW9wVThERENqTm9neHphVFBwT0xSbWdYb2lsZ0xxUU8yVnVxcURPRmFlZUdjWV82Y0xpT01XS3JnTQ?oc=5) |
| Yahoo Finance | Amylyx (AMLX) Climbs to Fresh High as Avexitide Moves Closer to Commercialization | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxOZkZjcGtnVFcteHRXLXlGY05fMHJtTnFTWG82Ui0yaGFNWE5ESk5CM1pYZld5UEpULUdwYjlHclQwcXFFYVdEaUVsWFhMOS16VXJuZlJudERBWjNFcXdMVnNkZDNQSW1rZkpIZHhhdlVEa1NJTlYtYlhMSTY5dW9HM3diZFJla2lfMDVCdlhHM2pYZ256?oc=5) |
| Yahoo Finance | Why Amylyx Pharmaceuticals Stock Skyrocketed Today | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxQVE52ZmJ6MmlhRVFTbVJubWFpUjFyS01zOHVRY2N1QWdHTkMzSXMxeVNPUXY5NlV3QVZKWkU1R3NMak4wbS1KTHhqdEF1X3V6WFlZMkRlVm5wY082cUxiVmhlU2xsY0tLRllNb1kyYjB2RERjUmtWTUphcDQ4RmVCeVIxZ3VKXzlDVzNnNV85WFVfT1lUbEsxSEZFejhPR1RERmR6LXMxS28?oc=5) |
| Fierce Biotech | Amylyx readies approval push after GLP-1 inhibitor halves blood sugar crashes in ph. 3 win | [Source Link](https://news.google.com/rss/articles/CBMiuwFBVV95cUxOdnBUa09yMXZ3Rk84MkRtc09jVk5hVkNxakw3WF80UzFOX05QY2pRNXdicmpXWjFQZWo4TXp4OWVrRkU3X2VSMXR6em5SS3JWb2tLM2hWamRHc3ZzbF9aQUo4djJSbi1MX3RlVU0wNmlSX1dScG8xbnJ4SWdFaFloOUhqOS02LVZQcXNWeFIyUUpldEMtV20tcVVDZjRIdEUtSnpodHduVVNldTJBY1M2dGVQWGJZUGctYVpV?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-08-19/amylyx-stock-surges-55-after-glp-1-blocker-hits-all-trial-goals*